Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Receivables - Other (2021 - 2023)

Historic Receivables - Other for Core Scientific (CORZ) over the last 3 years, with Q1 2023 value amounting to $2000.0.

  • Core Scientific's Receivables - Other fell 9941.52% to $2000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $2000.0, marking a year-over-year decrease of 9941.52%. This contributed to the annual value of $23000.0 for FY2022, which is 9233.33% down from last year.
  • According to the latest figures from Q1 2023, Core Scientific's Receivables - Other is $2000.0, which was down 9941.52% from $23000.0 recorded in Q4 2022.
  • Core Scientific's Receivables - Other's 5-year high stood at $895000.0 during Q3 2022, with a 5-year trough of $2000.0 in Q1 2023.
  • Moreover, its 3-year median value for Receivables - Other was $321000.0 (2021), whereas its average is $373166.7.
  • In the last 5 years, Core Scientific's Receivables - Other plummeted by 9233.33% in 2022 and then tumbled by 9941.52% in 2023.
  • Core Scientific's Receivables - Other (Quarter) stood at $300000.0 in 2021, then crashed by 92.33% to $23000.0 in 2022, then tumbled by 91.3% to $2000.0 in 2023.
  • Its Receivables - Other was $2000.0 in Q1 2023, compared to $23000.0 in Q4 2022 and $895000.0 in Q3 2022.